Market Research Logo

SynCardia Systems, Inc. - Product Pipeline Analysis, 2016 Update

Summary

SynCardia Systems, Inc. (SynCardia) develops and manufactures artificial human heart. Its flagship product, SynCardia temporary Total Artificial Heart (TAH-t) temporarily takes up the complete function of a failed human heart in patients suffering from final stage biventricular heart failure (BHF) before receiving a successful heart transplant. The TAH-t replaces the ventricles and four heart valves of a failing heart and eliminates the symptoms and source of end-stage BHF. SynCardia also offers the Freedom portable external pneumatic drivers, which power TAH-t and facilitate the discharge of clinically stable patients from the hospital, while waiting for a matching donor heart. The company offers TAH-t through certified centers in various parts of Europe, North America and Asia-Pacific. The company operates through its subsidiary, SynCardia Europe GmbH, in Germany. SynCardia is headquartered in Tucson, Arizona, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company SynCardia Systems, Inc.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio


SynCardia Systems, Inc. Company Snapshot
SynCardia Systems, Inc. Company Overview
Key Information
SynCardia Systems, Inc. Pipeline Products and Clinical Trials Overview
SynCardia Systems, Inc. – Pipeline Analysis Overview
Business Description
SynCardia Systems, Inc. - Major Products and Services
SynCardia Systems, Inc. Pipeline Products by Development Stage
SynCardia Systems, Inc. Clinical Trials by Trial Status
SynCardia Systems, Inc. Pipeline Products Overview
10cc Ventricular Assist Device
10cc Ventricular Assist Device Product Overview
30cc Ventricular Assist Device
30cc Ventricular Assist Device Product Overview
50cc Total Artificial Heart - Adults Bridge To Transplant
50cc Total Artificial Heart - Adults Bridge To Transplant Product Overview
50cc Total Artificial Heart - Adults Bridge To Transplant Clinical Trial
50cc Total Artificial Heart - Destination Therapy
50cc Total Artificial Heart - Destination Therapy Product Overview
50cc Total Artificial Heart - Pediatric Bridge To Transplant
50cc Total Artificial Heart - Pediatric Bridge To Transplant Product Overview
50cc Total Artificial Heart - Pediatric Bridge To Transplant Clinical Trial
60cc Ventricular Assist Device
60cc Ventricular Assist Device Product Overview
SynCardia Temporary 70cc Total Artificial Heart - Destination Therapy
SynCardia Temporary 70cc Total Artificial Heart - Destination Therapy Product Overview
SynCardia Temporary 70cc Total Artificial Heart - Destination Therapy Clinical Trial
SynCardia Systems, Inc. - Key Competitors
SynCardia Systems, Inc. - Key Employees
SynCardia Systems, Inc. - Key Employee Biographies
SynCardia Systems, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
SynCardia Systems, Inc., Recent Developments
Sep 22, 2015: SynCardia Provides Update Regarding Voluntary Recall of Potentially Affected Freedom Portable Drivers
Aug 18, 2015: The Start of SynCardia Total Artificial Heart Destination Clinical Study Wins Edison Awards’ Top Honor
Jun 15, 2015: SynCardia Systems - TAH-t Companion 2 Driver System - Letter to Health Care Providers
Apr 07, 2015: SynCardia Total Artificial Heart Featured in 12 ISHLT Abstracts
Mar 31, 2015: SynCardia Receives FDA Approval To Conduct New IDE Trial Of 50cc Total Artificial Heart
Mar 10, 2015: Medical Journal Describes 2 Consecutive SynCardia Total Artificial Heart Patients Bridged to Dual Heart-Kidney Transplants
Feb 24, 2015: Dan Hudspeth Joins SynCardia Systems As Chief Financial Officer
Feb 17, 2015: Patients Supported for More Than 1 Year by the SynCardia Total Artificial Heart Experienced Acceptable Outcomes, Concludes International Study
Jan 21, 2015: Michigan Man First in State to be Discharged from the Hospital without a Human Heart
Jan 12, 2015: Tim Shannon Joins SynCardia Systems as Executive Vice President, Global Commercialization
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
SynCardia Systems, Inc., Key Facts
SynCardia Systems, Inc. Pipeline Products and Clinical Trials Overview
SynCardia Systems, Inc. Pipeline Products by Equipment Type
SynCardia Systems, Inc. Pipeline Products by Indication
SynCardia Systems, Inc. Clinical Trials by Trial Status
SynCardia Systems, Inc., Major Products and Services
SynCardia Systems, Inc. Number of Pipeline Products by Development Stage
SynCardia Systems, Inc. Pipeline Products Summary by Development Stage
SynCardia Systems, Inc. Clinical Trials by Trial Status
SynCardia Systems, Inc. Clinical Trials Summary
10cc Ventricular Assist Device - Product Status
10cc Ventricular Assist Device - Product Description
30cc Ventricular Assist Device - Product Status
30cc Ventricular Assist Device - Product Description
50cc Total Artificial Heart - Adults Bridge To Transplant - Product Status
50cc Total Artificial Heart - Adults Bridge To Transplant - Product Description
50cc Total Artificial Heart - Adults Bridge To Transplant - Investigational Device Exemption study of Use of the New 50cc SynCardia Heart
50cc Total Artificial Heart - Destination Therapy - Product Status
50cc Total Artificial Heart - Destination Therapy - Product Description
50cc Total Artificial Heart - Pediatric Bridge To Transplant - Product Status
50cc Total Artificial Heart - Pediatric Bridge To Transplant - Product Description
50cc Total Artificial Heart - Pediatric Bridge To Transplant - Investigational Device Exemption study of Use of the New 50cc SynCardia Heart
60cc Ventricular Assist Device - Product Status
60cc Ventricular Assist Device - Product Description
SynCardia Temporary 70cc Total Artificial Heart - Destination Therapy - Product Status
SynCardia Temporary 70cc Total Artificial Heart - Destination Therapy - Product Description
SynCardia Temporary 70cc Total Artificial Heart - Destination Therapy - SynCardia 70cc Temporary Total Artificial Heart (TAH-t) for Destination Therapy (DT)
SynCardia Systems, Inc., Key Employees
SynCardia Systems, Inc., Key Employee Biographies
SynCardia Systems, Inc., Subsidiaries
List of Figures
SynCardia Systems, Inc. Pipeline Products by Equipment Type
SynCardia Systems, Inc. Pipeline Products by Development Stage
SynCardia Systems, Inc. Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report